Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.
Yan Y, Zhou B, Qian C, Vasquez A, Kamra M, Chatterjee A, Lee YJ, Yuan X, Ellis L, Di Vizio D, Posadas EM, Kyprianou N, Knudsen BS, Shah K, Murali R, Gertych A, You S, Freeman MR, Yang W.
Yan Y, et al. Among authors: yang w.
Nat Commun. 2022 Feb 3;13(1):669. doi: 10.1038/s41467-022-28340-6.
Nat Commun. 2022.
PMID: 35115556
Free PMC article.